Effect of sugammadex versus neostigmine/glycopyrrolate combination on peak expiratory flow rates in adult patients undergoing laparoscopic surgery
Open Access
- 20 May 2026
- journal article
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 70 (5) , 653-661
Abstract
Background and Aims: Residual neuromuscular blockade impacts peak expiratory flow rate (PEFR). The primary aim of this study was to compare post-extubation PEFR in adults undergoing laparoscopic cholecystectomy when neuromuscular blockade was reversed by either neostigmine or sugammadex. Methods: Patients aged 18–60 years were randomised into two equal groups of 43 each based on the reversal agent used – sugammadex versus neostigmine. Pre- and post-operative PEFRs were recorded using a handheld flow-type spirometer. Percentage reduction in forced expiratory volume in first second (FEV1), forced vital capacity (FVC), and FEV1/FVC were calculated. Adverse events and recovery scores were compared between the two groups. Results: The post-operative PEFR with sugammadex was 336.88 ± 65.94 L/min, compared to 293.93 ± 43.76 L/min with neostigmine. The mean difference was statistically significant {42.95 L/min [95% confidence interval (CI): 18.95–66.95 L/min], P = 0.001}. The mean percentage reduction in PEFR from baseline was significantly lower with sugammadex (9.66 ± 6.11%) compared to neostigmine (16.33 ± 10.9%). The median time to extubation with sugammadex was 3 min [interquartile range (IQR): 3–4)], and 7 min (IQR: 6–8) with neostigmine ( P = 0.001). The time to achieve modified Aldrete score >8 with sugammadex was shorter by an absolute difference of 8.814 (CI = 10.28–7.35) min. No incidence of post-operative pulmonary complication (PPC) was reported in either group. Conclusion: Reversal of neuromuscular blockade with sugammadex is associated with higher post-operative values of PEFR when compared with neostigmine. Higher values of PEFR and FEV1, FVC, and FEV 1 /FVC ratio after surgery shorten the time to extubation, minimise PPC, and facilitate early post-operative recovery.Keywords
This publication has 17 references indexed in Scilit:
- Sugammadex vs neostigmine in post-anesthesia recovery: A systematic review and meta-analysisBiomolecules and Biomedicine, 2025
- Relation of changes in peak expiratory flow (PEF) and forced expiratory volume in 1 s (FEV1) during bronchoconstrictionClinical Physiology and Functional Imaging, 2024
- Establishing an optimal diagnostic criterion for respiratory sarcopenia using peak expiratory flow rateAging Clinical and Experimental Research, 2024
- Maximal respiratory pressures: Measurements at functional residual capacity in individuals with different health conditions using a digital manometerBrazilian Journal of Physical Therapy, 2023
- Sugammadex Versus Neostigmine for Recovery of Respiratory Muscle Strength Measured by Ultrasonography in the Postextubation Period: A Randomized Controlled TrialAnesthesia & Analgesia, 2022
- Comparison of the effects of neostigmine and sugammadex on postoperative residual curarization and postoperative pulmonary complications by means of diaphragm and lung ultrasonography: a study protocol for prospective double-blind randomized controlled trialTrials, 2022
- Peri-operative diaphragm ultrasound as a new method of recognizing post-operative residual curarizationBMC Anesthesiology, 2021
- A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the USAdvances in Therapy, 2021
- Sugammadex is associated with better respiratory recovery than neostigmine following reversal of anaesthesia-associated neuromuscular blockade in the morbidly obese patients following elective laparoscopic surgeryLaparoscopic, Endoscopic and Robotic Surgery, 2018
- Asthma outcomes: Pulmonary physiologyJournal of Allergy and Clinical Immunology, 2012